IL83594A0 - Human low affinity fce-receptor,its isolation,its recombinant preparation and pharmaceutical compositions containing it - Google Patents

Human low affinity fce-receptor,its isolation,its recombinant preparation and pharmaceutical compositions containing it

Info

Publication number
IL83594A0
IL83594A0 IL83594A IL8359487A IL83594A0 IL 83594 A0 IL83594 A0 IL 83594A0 IL 83594 A IL83594 A IL 83594A IL 8359487 A IL8359487 A IL 8359487A IL 83594 A0 IL83594 A0 IL 83594A0
Authority
IL
Israel
Prior art keywords
fce
receptor
isolation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL83594A
Other languages
English (en)
Original Assignee
Kishimoto Tadamitsu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP86111581A external-priority patent/EP0257114A1/fr
Priority claimed from EP87105425A external-priority patent/EP0286700A1/fr
Application filed by Kishimoto Tadamitsu filed Critical Kishimoto Tadamitsu
Publication of IL83594A0 publication Critical patent/IL83594A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL83594A 1986-08-21 1987-08-20 Human low affinity fce-receptor,its isolation,its recombinant preparation and pharmaceutical compositions containing it IL83594A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP86111581A EP0257114A1 (fr) 1986-08-21 1986-08-21 Récepteur Fc-epsilon humain à affinité réduite, son isolement et sa purification
EP86113073A EP0258489A1 (fr) 1986-08-21 1986-09-23 Récepteur Fc-epsilon humain, à affinité réduite, son isolement et sa purification
EP86116938A EP0258492A1 (fr) 1986-08-21 1986-12-05 Récepteur Fc-epsilon humain à affinité réduite, son isolement et sa purification
EP87105425A EP0286700A1 (fr) 1987-04-11 1987-04-11 Fragment FcR humain recombinant et soluble, ayant une activité biologique, plasmides codant pour ce fragment FcR, ainsi que sa préparation

Publications (1)

Publication Number Publication Date
IL83594A0 true IL83594A0 (en) 1988-01-31

Family

ID=27440992

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83594A IL83594A0 (en) 1986-08-21 1987-08-20 Human low affinity fce-receptor,its isolation,its recombinant preparation and pharmaceutical compositions containing it

Country Status (10)

Country Link
EP (1) EP0259615A1 (fr)
JP (1) JPS6427496A (fr)
AU (1) AU7716587A (fr)
DK (1) DK434287A (fr)
FI (1) FI873614A (fr)
HU (1) HUT44620A (fr)
IL (1) IL83594A0 (fr)
NO (1) NO873512L (fr)
NZ (1) NZ221501A (fr)
PT (1) PT85560B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0254249B1 (fr) * 1986-07-22 1992-08-19 Ciba-Geigy Ag Préparation de polypeptides parents à facteur de liaison
EP0324879A1 (fr) * 1988-01-20 1989-07-26 Kishimoto, Tadamitsu, Prof. Récepteur Fe-Epsilon soluble et recombinant, sa préparation ainsi que son utilisation
EP0321601A1 (fr) * 1987-12-22 1989-06-28 Kishimoto, Tadamitsu, Prof. Récepteur Fc-epsilon soluble et recombinant, sa préparation ainsi que son utilisation
US5958880A (en) * 1996-12-19 1999-09-28 Heska Corporation Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof
EP1006183A1 (fr) 1998-12-03 2000-06-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Récepteurs Fc recombinantes et solubles
EP2860195A1 (fr) * 2009-12-01 2015-04-15 Boston Medical Center Corporation Traitement de maladies à médiation par IgE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0248211B1 (fr) * 1986-04-30 1992-03-11 Junji Yodoi Protéine et son procédé de préparation

Also Published As

Publication number Publication date
NO873512D0 (no) 1987-08-20
PT85560B (pt) 1990-05-31
DK434287A (da) 1988-02-22
HUT44620A (en) 1988-03-28
NO873512L (no) 1988-02-22
PT85560A (en) 1987-09-01
JPS6427496A (en) 1989-01-30
NZ221501A (en) 1990-08-28
FI873614A (fi) 1988-02-22
EP0259615A1 (fr) 1988-03-16
FI873614A0 (fi) 1987-08-21
AU7716587A (en) 1988-05-19
DK434287D0 (da) 1987-08-20

Similar Documents

Publication Publication Date Title
IL84315A0 (en) Hydrogenated phenylbenzopyrans,their preparation and pharmaceutical compositions containing them
IL84723A0 (en) Substituted basic 2-amino-tetralins,their preparation and pharmaceutical compositions containing them
IL81930A0 (en) Oxadiazoles,their preparation and pharmaceutical compositions containing them
IL85136A0 (en) Peptide derivatives,their preparation and pharmaceutical compositions containing them
IL82671A0 (en) 1,5-diaryl-3-substituted-pyrazoles,their preparation and pharmaceutical compositions containing them
IL81322A0 (en) Thieno-1,4-diazepines,their preparation and pharmaceutical compositions containing them
IL79323A (en) Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
IL84302A (en) Substituted :-aminoacids, their preparation and pharmaceutical compositions containing them
IL84060A0 (en) Imidazobenzoxazinones,their preparation and pharmaceutical compositions containing them
IL84832A (en) 6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5- tetrahydropyridazin-3- ones, their preparation and pharmaceutical compositions containing them
IL87644A0 (en) Oxadiazolyl-azabicycloheptanes,their preparation and pharmaceutical compositions containing them
IL84484A0 (en) T-cell suppressor protein in pure form,its preparation by recombinant methods and pharmaceutical compositions containing it
IL86876A0 (en) Polypeptides,their preparation and pharmaceutical composition containing them
IL85885A0 (en) Cyclic peptides,their preparation and pharmaceutical compositions containing them
IL94884A0 (en) Vip analogs,their preparation and pharmaceutical compositions containing them
IL79039A0 (en) 4-oxoquinolinesulfonamides,their preparation and pharmaceutical compositions containing them
IL82894A0 (en) Androst-4-ene-3,17-diones,their preparation and pharmaceutical compositions containing them
IL76956A0 (en) Antibiotic polypeptide,its preparation and pharmaceutical compositions containing it
IL83594A0 (en) Human low affinity fce-receptor,its isolation,its recombinant preparation and pharmaceutical compositions containing it
IL86478A0 (en) Substituted vinylcephalosporins,their preparation and pharmaceutical compositions containing them
IL88934A0 (en) Recombinant human interleukin-1alpha polypeptides,their preparation and pharmaceutical compositions containing them
IL86926A0 (en) 1h-pyrazole-1-alkanamides,their preparation and pharmaceutical compositions containing them
IL83101A0 (en) Substituted hexahydro arylquinolizines,their preparation and pharmaceutical compositions containing them
IL88743A0 (en) Soluble recombinant fcepsilon-receptor,its preparation and pharmaceutical compositions containing it
GB2196958B (en) Halo-homostatin peptide derivatives ,their preparation and pharmaceutical compositions containing them